Repertoire Bio
Building the world’s largest digital immune repertoire to power therapeutic discovery
Repertoire Bio
Building the world’s largest digital immune repertoire to power therapeutic discovery
Building the world’s largest digital immune repertoire to power therapeutic discovery
Building the world’s largest digital immune repertoire to power therapeutic discovery
Repertoire Bio is a drug discovery platform spun out from the University of Oxford. We leverage advanced BCR and TCR sequencing through our innovative DeepRep technology. This approach delivers millions of paired-chain single cell resolution clonotypes at fractions of a cent, a paradigm shift in drug discovery.
Peter Medawar Building for Pathogen Research, South Parks Road, Oxford, UK
Repertoire Bio brings together a team of Oxford scientists committed to transforming drug discovery. By analysing B-cell and T-cell receptor repertoires at unprecedented depth, we aim to uncover the immune system’s hidden patterns and drive the next wave of biotherapeutic innovation.
Innovation is at the core of what we do at Repertoire Bio. We continually push the boundaries of biotechnology, developing advanced tools that have the potential to redefine how drugs are discovered and designed.
Repertoire Bio